Reconstruction and Analysis of a Genome-Scale Metabolic Model of Acinetobacter lwoffii
- PMID: 39273268
- PMCID: PMC11395192
- DOI: 10.3390/ijms25179321
Reconstruction and Analysis of a Genome-Scale Metabolic Model of Acinetobacter lwoffii
Abstract
Acinetobacter lwoffii is widely considered to be a harmful bacterium that is resistant to medicines and disinfectants. A. lwoffii NL1 degrades phenols efficiently and shows promise as an aromatic compound degrader in antibiotic-contaminated environments. To gain a comprehensive understanding of A. lwoffii, the first genome-scale metabolic model of A. lwoffii was constructed using semi-automated and manual methods. The iNX811 model, which includes 811 genes, 1071 metabolites, and 1155 reactions, was validated using 39 unique carbon and nitrogen sources. Genes and metabolites critical for cell growth were analyzed, and 12 essential metabolites (mainly in the biosynthesis and metabolism of glycan, lysine, and cofactors) were identified as antibacterial drug targets. Moreover, to explore the metabolic response to phenols, metabolic flux was simulated by integrating transcriptomics, and the significantly changed metabolism mainly included central carbon metabolism, along with some transport reactions. In addition, the addition of substances that effectively improved phenol degradation was predicted and validated using the model. Overall, the reconstruction and analysis of model iNX811 helped to study the antimicrobial systems and biodegradation behavior of A. lwoffii.
Keywords: Acinetobacter lwoffii; drug targets; genome-scale metabolic model; phenol degradation.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Comparative Genomic and Transcriptomic Analysis of Phenol Degradation and Tolerance in Acinetobacter lwoffii through Adaptive Evolution.Int J Mol Sci. 2023 Nov 20;24(22):16529. doi: 10.3390/ijms242216529. Int J Mol Sci. 2023. PMID: 38003719 Free PMC article.
-
Analysis of Phenol Biodegradation in Antibiotic and Heavy Metal Resistant Acinetobacter lwoffii NL1.Front Microbiol. 2021 Sep 10;12:725755. doi: 10.3389/fmicb.2021.725755. eCollection 2021. Front Microbiol. 2021. PMID: 34566929 Free PMC article.
-
Characterization of a new catechol branch of the beta-ketoadipate pathway induced for benzoate degradation in Acinetobacter lwoffii K24.Biochem Biophys Res Commun. 2007 Aug 31;360(3):513-9. doi: 10.1016/j.bbrc.2007.05.132. Epub 2007 May 30. Biochem Biophys Res Commun. 2007. PMID: 17610839
-
Four novel Acinetobacter lwoffii strains isolated from the milk of cows in China with subclinical mastitis.BMC Vet Res. 2024 Jun 26;20(1):274. doi: 10.1186/s12917-024-04119-3. BMC Vet Res. 2024. PMID: 38918815 Free PMC article.
-
Acinetobacter baylyi ADP1 as a model for metabolic system biology.Curr Opin Microbiol. 2009 Oct;12(5):568-76. doi: 10.1016/j.mib.2009.07.005. Epub 2009 Aug 24. Curr Opin Microbiol. 2009. PMID: 19709925 Review.
References
-
- Touchon M., Cury J., Yoon E.-J., Krizova L., Cerqueira G.C., Murphy C., Feldgarden M., Wortman J., Clermont D., Lambert T., et al. The Genomic Diversification of the Whole Acinetobacter Genus: Origins, Mechanisms, and Consequences. Genome Biol. Evol. 2014;6:2866–2882. doi: 10.1093/gbe/evu225. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources